LBP AM’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,061
Closed -$3.9M 420
2025
Q3
$3.9M Buy
+12,061
New +$3.75M 0.05% 238
2025
Q2
Sell
-2,914
Closed -$1.27M 380
2025
Q1
$1.27M Buy
+2,914
New +$1.17M 0.02% 299
2024
Q4
Sell
-2,091
Closed -$1.09M 380
2024
Q3
$1.09M Sell
2,091
-1,921
-48% -$1.03M 0.02% 290
2024
Q2
$2.17M Sell
4,012
-26
-0.6% -$13.7K 0.09% 155
2024
Q1
$2.09M Sell
4,038
-8,036
-67% -$4M 0.08% 168
2023
Q4
$5.69M Sell
12,074
-4,859
-29% -$2.25M 0.13% 163
2023
Q3
$7.37M Buy
16,933
+10,462
+162% +$4.75M 0.16% 149
2023
Q2
$2.88M Sell
6,471
-7,237
-53% -$3.34M 0.07% 210
2023
Q1
$6.3M Sell
13,708
-896
-6% -$426K 0.16% 132
2022
Q4
$7.49M Buy
+14,604
New +$7.42M 0.21% 99

Other funds holding ELV

LBP AM's ELV Position: Q4 2025 in Review

LBP AM sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 12,061 shares — an estimated $3.9M sold.

LBP AM first reported a position in ELV in Q4 2022 and held it in 10 quarters. The position peaked at $7.49M in Q4 2022. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • LBP AM reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • LBP AM sold 12,061 Elevance Health shares in Q4 2025, an estimated $3.9M.
  • LBP AM first reported a position in Elevance Health in Q4 2022 and held it in 10 quarters.
  • LBP AM's Elevance Health position peaked at $7.49M in Q4 2022.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on LBP AM's 13F filing for Q4 2025, filed 26 Jan 2026.